Leevi
ALStuttu:n jäsen
ALS:iin läheisesti liittyvän FTD-taudin FinFTD-symposiumi Kuopiossa 13.9.2019, aihealueen tutkijoille:
https://www.uef.fi/fi/web/finftd/symposium
2nd FinFTD Symposium September 13, 2019
"We are happy to announce that the 2nd FinFTD symposium will take place in Kuopio in September 2019!
The 1st FinFTD research day was arranged in Kuopio in April 2016. Research projects on clinical, biomarker, and mechanistic studies on frontotemporal dementia (FTD) were presented by research groups from Kuopio and Oulu. The 2nd FinFTD symposium will now be expanded to cover nationwide and international research on FTD and related disorders.
Frontotemporal lobar degeneration, including FTD, is a heterogeneous group of progressive neurodegenerative syndromes affecting the frontal and temporal lobes of the brain. The patients are characterized by changes in behavior and personality and sometimes language or motor impairments. The prediction and diagnosis of FTD are challenging because of the current lack of specific biomarkers, often overlapping clinical features with other brain diseases, and poorly understood molecular mechanisms that underlie the disease. The hexanucleotide repeat expansion of the C9orf72 gene is the most common genetic cause underlying FTD and also the motoneuron disease amyotrophic lateral sclerosis (ALS), indicating overlapping genetic background and underlying mechanisms in these diseases. These issues will be discussed in the 2nd FinFTD symposium.
We warmly welcome all researchers and health care professionals involved or interested in the research and care of FTD or related diseases to join the symposium, share their research, and network with others!
https://www.uef.fi/fi/web/finftd/symposium
2nd FinFTD Symposium September 13, 2019
"We are happy to announce that the 2nd FinFTD symposium will take place in Kuopio in September 2019!
The 1st FinFTD research day was arranged in Kuopio in April 2016. Research projects on clinical, biomarker, and mechanistic studies on frontotemporal dementia (FTD) were presented by research groups from Kuopio and Oulu. The 2nd FinFTD symposium will now be expanded to cover nationwide and international research on FTD and related disorders.
Frontotemporal lobar degeneration, including FTD, is a heterogeneous group of progressive neurodegenerative syndromes affecting the frontal and temporal lobes of the brain. The patients are characterized by changes in behavior and personality and sometimes language or motor impairments. The prediction and diagnosis of FTD are challenging because of the current lack of specific biomarkers, often overlapping clinical features with other brain diseases, and poorly understood molecular mechanisms that underlie the disease. The hexanucleotide repeat expansion of the C9orf72 gene is the most common genetic cause underlying FTD and also the motoneuron disease amyotrophic lateral sclerosis (ALS), indicating overlapping genetic background and underlying mechanisms in these diseases. These issues will be discussed in the 2nd FinFTD symposium.
We warmly welcome all researchers and health care professionals involved or interested in the research and care of FTD or related diseases to join the symposium, share their research, and network with others!
- The 2nd FinFTD symposium program will include:
Confirmed two keynote lectures given by international experts:- Associate Professor Barbara Borroni (Brescia, Italy) and
- Professor Alberto Lleó (Barcelona, Spain)
- Short talks selected from abstracts
- Poster and networking session"